Sánchez-Díaz, Carola T.
Zeinomar, Nur
Iyer, Hari S.
Perlstein, Marley
Gonzalez, Brian D.
Hong, Chi-Chen
Bandera, Elisa V.
Qin, Bo
Funding for this research was provided by:
New Jersey Commission on Cancer Research (COCR23PDF029)
National Cancer Institute (R01CA185623, R01CA185623)
American Cancer Society (RSG-23-1143513-01-CTPS)
Article History
Received: 28 November 2023
Accepted: 20 March 2024
First Online: 1 April 2024
Declarations
:
: The authors declare no competing interests.
: Dr. Bandera reported receiving personal fees from Pfizer Inc outside the submitted work. Dr. Gonzalez reported fees unrelated to this work from Sure Med Compliance and Elly Health. No other conflicts were reported.